JBI-802 is a novel, oral, potent and selective dual inhibitor of two epigenetic targets of the CoREST complex: LSD1 and HDAC6
The hospital has recently launched Radionuclide therapy
Trastuzumab is monoclonal antibody used to treat human epidermal growth factor receptor 2 positive (HER2+) breast cancer and metastatic gastric cancers
2022 is going to be the year of opportunities and innovations from the medical industry in India
The event was organized jointly by Oncology Forum and Fortis Cancer Institute, Delhi NCR
It is the first targeted fluorescent imaging agent that illuminates ovarian cancer intraoperatively, enabling the detection of more cancer for removal
Fyarro is the first and only approved therapy for adults for the treatment of malignant PEComa in adults
_256_384.jpg)
India registers 18% of deaths annually due to air pollution while seven million die annually across the world due to air pollution
It is the first blood test able to detect early-stage Breast Cancer with high accuracy in women above the age of 40 years
It is used for the treatment of advanced colorectal and gastric cancer
Subscribe To Our Newsletter & Stay Updated
